Northpointe Capital’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-114,275
Closed -$5.68M 95
2019
Q2
$5.68M Sell
114,275
-5,627
-5% -$264K 1.8% 11
2019
Q1
$5.1M Buy
+119,902
New +$5.3M 1.61% 16
2016
Q3
Sell
-108,777
Closed -$3.86M 198
2016
Q2
$3.86M Buy
+108,777
New +$4.24M 0.46% 71
2016
Q1
Sell
-63,847
Closed -$2.68M 252
2015
Q4
$2.68M Hold
63,847
0.35% 110
2015
Q3
$2.68M Buy
63,847
+6,485
+11% +$303K 0.35% 111
2015
Q2
$2.86M Buy
57,362
+9,495
+20% +$450K 0.34% 100
2015
Q1
$2.16M Buy
47,867
+3,480
+8% +$156K 0.23% 142
2014
Q4
$2.14M Buy
44,387
+3,785
+9% +$180K 0.26% 136
2014
Q3
$1.94M Buy
40,602
+257
+0.6% +$12.5K 0.21% 141
2014
Q2
$2M Buy
+40,345
New +$1.89M 0.19% 149

Other funds holding MET

Northpointe Capital's MET Position: Q3 2019 in Review

Northpointe Capital sold out of MetLife (MET) in Q3 2019, closing a stake of 114,275 shares — an estimated $5.68M sold.

Northpointe Capital first reported a position in MET in Q2 2014 and held it in 10 quarters. The position peaked at $5.68M in Q2 2019. 1,043 funds tracked by Wall St. Rank hold MET as of Q3 2019.

  • Northpointe Capital reported no remaining MetLife position as of Q3 2019 after selling out during the quarter.
  • Northpointe Capital sold 114,275 MetLife shares in Q3 2019, an estimated $5.68M.
  • Northpointe Capital first reported a position in MetLife in Q2 2014 and held it in 10 quarters.
  • Northpointe Capital's MetLife position peaked at $5.68M in Q2 2019.
  • 1,043 funds tracked by Wall St. Rank held MetLife as of Q3 2019.

Based on Northpointe Capital's 13F filing for Q3 2019, filed 16 Oct 2019.